$850 | SAVE $150 |

India Rising Stars Outlook 2015: Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there
[Published by MP Advisors]

Published by MP Advisors: 21 Jan 2015 | 20121 | In Stock

Introduction

Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there. However, there have a been a new generation of entrepreneurs who have who ventured into the drug discovery path backed by VC funding and no pharma heritage ! In this Outlook we highlight the names of some select innovation/drug discovery companies who have successfully raised funds to sustain the research, out-licensed some of their assets or are likely to do so in the next 2-3 years thereby rewarding their investors. . In this Outlook we have initiated coverage on Connexios, Bugworks, Cellworks, Tergene and hope that soon we will be able to expand the universe further.

Table of Contents
for India Rising Stars Outlook 2015: Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there [Published by MP Advisors]

  • Company Analysis : Connexious - Connexios has had a bumpy ride like most Rising stars/drug discovery

    companies in the biotech sector

    • Technology Platform

    • Therapy Focus—Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)

    • Key Milestones

    • Figure 1: PRODUCTS IN PIPELINE- DIABETES

    • Figure 2: PRODUCTS IN PIPELINE FOR NASH

    • Figure 3: OTHER PROGRAMS

    • Appendix 1: Network Biology Platform for Diabetes and fibrosis

    • Appendix:2 Novel GPR40 agonist

    • CNX-103: Whole body improvement of metabolic health

    • Table 1: Differences Between G-Protein Coupled receptor agonists

    • Table 2: Pipeline Of Gpr Agonist For Treatment Of Type 2 Diabetes

    Cellworks - Cellworks (CW) has evolved from a service based company to a drug discovery

    /development company on the strength of its proprietary Virtual Prototyping

    platform that allows simulation of cell types//disease in silico.

    • Technology Platform

    • Pipeline

    • Figure 1: Simulation Based personalization

    • Figure 2: Cellworks Therapeutic Programs

    Bugworks - Bugworks is a validation of Cellworks simulation in silico Technology Platform where

    its Bugworks Microbial Platform (BMP) combines functional proteomics with

    sophisticated semiconductor designe engineering to model and manipulate various

    bacterial systems.

    • Therapy focus- Serious Hospital Infection

    • Technology Platform

    • Need of the Hour- New Targets= New Antibiotic Class

    • The GAIN Act

    • Figure 1: Drug Development Success For Tb

    • Figure 2: Going Way Froward : focus: Helathcare Associated Infections

    Tergene - Tergene’s first product in development is a vaccine for pneumonia caused by, Streptococcus pneumonia (pneumococcous). The available vaccine The Pneumococcal

    Polysaccharide Vaccines (PPV)

    • Development Strategy and Status-

    • Long term plans-

    • Vaccine Market-

    • Figure 1: sales of currently available vaccines for streptococcus pneumonia

    • Figure 2: Ww Demand Forecast Of Vaccines For Streptococcus Pneumonia

    • Figure 3: Vaccine Market

Additional Details

Publisher

MP Advisors

Publisher Information

Reference

20121 | 4476

Number of Pages

22

Report Format

PDF

MP Advisors Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review
SummarySanofi India Limited (Sanofi India),a subsidiary of Sanofi is a pharmaceutical company that p...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Pfizer Limited, India (PFIZER) - Financial and Strategic SWOT Analysis Review
SummaryPfizer Limited, India (Pfizer India), a subsidiary of Pfizer Inc is a pharmaceutical company ...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Novartis India Limited (500672) - Financial and Strategic SWOT Analysis Review
SummaryNovartis India Limited (Novartis), a subsidiary of Novartis AG is a pharmaceutical company th...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Opto Circuits India Limited (OPTOCIRCUI) - Financial and Strategic SWOT Analysis Review
SummaryOpto Circuits India Limited (OCI) is a medical device company that designs, develops, manufac...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Parenteral Drug India Ltd. (PDPL) - Financial and Strategic SWOT Analysis Review
SummaryParenteral Drug India Ltd. (Parenteral Drugs) is a pharmaceutical company that discovers, res...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Kilitch Drugs (India) Ltd. (KILITCH) - Financial and Strategic SWOT Analysis Review
SummaryKilitch Drugs (India) Ltd. (Kilitch) is a pharmaceutical company that manufactures and market...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Fulford (India) Limited (506803) - Financial and Strategic SWOT Analysis Review
SummaryFulford (India) Limited (Fulford) a subsidiary of Merck & Co. Inc., is a pharmaceutical compa...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic SWOT Analysis Review
SummaryAhlcon Parenterals (India) Limited (APIL), subsidiary of B. Braun Singapore Pte Ltd, is a pha...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Opto Circuits India Limited (OPTOCIRCUI) - Medical Equipment - Deals and Alliances Profile
SummaryOpto Circuits India Limited (OCI) is a medical device company that designs, develops, manufac...
23 Oct 2015 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Sutures India Private Limited - Medical Equipment - Deals and Alliances Profile
SummarySutures India Private Limited (SIPL) is a medical device company that manufactures and distri...
23 Oct 2015 by Global Data USD $213 (normally
USD $251)
More Info

This report is published by MP Advisors

Download Free Report Summary PDF

India Rising Stars  Outlook 2015: Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there [Published by MP Advisors] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...